estrogen positive breast cancer and alcohol

Release time ：Dec-20,2024

There is a recognized link between estrogen receptor-positive (ER+) breast cancer patients and alcohol consumption, with drinking potentially having detrimental health implications for these individuals.

Firstly, alcohol is known to be carcinogenic, and excessive intake can heighten the risk of developing breast cancer. For those already diagnosed with ER+ breast cancer, alcohol consumption may worsen the disease, contributing to tumor growth and metastasis. Secondly, alcohol can impair liver function, which is crucial for the metabolism and elimination of estrogen. Elevated estrogen levels may foster the growth and multiplication of cancer cells. Moreover, alcohol can also impact immune system function, diminishing the body's capacity to detect and eliminate cancer cells.

Hence, it is advisable for ER+ breast cancer patients to abstain from alcohol. In their daily lives, patients should focus on maintaining a healthy diet rich in fruits and vegetables while reducing the intake of high-fat and high-calorie foods. Regular health check-ups are essential to closely monitor disease progression and to follow medical advice for treatment. With a physician's guidance, patients can also engage in physical activities to enhance their physical fitness and immune response. In conclusion, ER+ breast cancer patients are encouraged to avoid alcohol, maintain a healthy lifestyle, and actively engage in treatment as directed by their healthcare providers.